Rates of Major Adverse Cardiovascular (CV) Events (MACE) and Mortality with Basal Insulin by Liraglutide Use-A DEVOTE Subanalysis

2018-07-01

1

PRE

AI

DOI：10.2337/db18-1065-P

Original

Original request for help

Share

Save